We have now numerous great personnel members good at advertising, QC, and working with kinds of troublesome dilemma from the creation course of action for Dengue Combo Rapid Test, In Vitro Clinical Diagnostics, Brucella Igg/Igm Antibody Test, Our merchandise delight in excellent popularity among our buyers. We welcome consumers, business enterprise associations and good friends from all components with the globe to make contact with us and seek out cooperation for mutual rewards.
2022 Latest Design Rdt Test For Dengue - Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His) – Bioantibody Detail:
Product details
Recombinant SARS-CoV-2 Nucleocapsid Protein is produced by Escherichia coli expression system and the target gene Met1-Ala419 is expressed with 6 HIS tag at the N-terminus. Consists of 428 amino acids and predicts a molecular mass of 46.6 kDa.

Properties
| Purity |
≥95% (SDS-PAGE) |
| Molecular Mass |
46.6 kDa |
| Product Buffer |
20mM PB, 150mM NaCl, 10%Glycerol, pH8.0. |
| Storage |
Store at -20℃ to -80℃. Avoid multiple freeze/thaw cycles. |
Order Information
| Product Name |
Cat. No |
Quantity |
| Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His) |
AG0046 |
Customized |
Product detail pictures:
Related Product Guide:
We can always satisfy our respected customers with our good quality, good price and good service due to we are more professional and more hard-working and do it in cost-effective way for 2022 Latest Design Rdt Test For Dengue - Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His) – Bioantibody , The product will supply to all over the world, such as: Romania, Canberra, Uruguay, Over the years, with high-quality solutions, first- class service, ultra-low prices we win thee trust and favor of customers. Nowadays our products sell all over the domestic and abroad. Thanks for the regular and new customers support. We offer high quality product and competitive price, welcome the regular and new customers cooperate with us!